AbbVie (ABBV), Enanta (ENTA) Active Following Gilead's (GILD) HCV Treatment Update

Go back to AbbVie (ABBV), Enanta (ENTA) Active Following Gilead's (GILD) HCV Treatment Update
AbbVie (NYSE: ABBV) Delayed: 267.21 +2.87 (1.09%)
Previous Close $264.34    52 Week High $68.12 
Open $264.33    52 Week Low $50.71 
Day High $267.74    P/E 57.96 
Day Low $263.38    EPS $4.61 
Volume 1,697,443       

ENANTA PHARM (NASDAQ: ENTA) Delayed: 12.42 +0.54 (4.55%)
Previous Close $11.88    52 Week High $34.49 
Open $11.88    52 Week Low $20.39 
Day High $12.54    P/E N/A 
Day Low $11.69    EPS $-3.18 
Volume 214,491       

Gilead Sciences (NASDAQ: GILD) Delayed: 152.26 +1.33 (0.88%)
Previous Close $150.93    52 Week High $108.63 
Open $149.80    52 Week Low $71.39 
Day High $152.48    P/E 84.12 
Day Low $149.41    EPS $1.81 
Volume 2,447,537